It won't let me post attachments but here is report (thanks to The Kid for supplying)
I have deleted sources, a bit hard to read as copied from PDF.
REPORTING FORM ON NEW
PSYCHOACTIVE DRUG
In accordance with Council Decision 2005/387/JHA of
10 May 2005 on information exchange, risk
assessment and control of new psychoactive
substances.
This section should be filled in by Europol or EMCDDA
Transmitted by Europol Transmitted by EMCDDA
Ref. nº: OEDT/EPI (08) D/30055 Date of transmission: 20/10/08
The following sections should be filled by the Europol National Units (ENU) or REITOX
National Focal Points (NFP) based on the information available and their respective
competences
1. Member State: UK
Ref. n°: Date:15 October 2008
Reporting authority:
ENU REITOX
2. Chemical name: 3-Fluoromethcathinone
Other name(s): The β-keto analogue of 3-fluoromethamphetamine; 2-methylamino-
1-(3-fluorophenyl)propan-1-one
Street name(s): Various
3. Source of information (fill one or more as appropriate)
Seizure(s) Specify amount (weight, number of tablets, etc.):
Seizing authority:
Date: Place:
Biological sample(s)1 Specify type:
Identifying authority:
Date: Place:
Collected sample(s)2 Specify amount (weight, number of tablets, etc):
Collecting authority: TICTAC Communications, Toxicology Unit, St. George’s
Hospital Medical School, London, SW17 0RE. Structure confirmed by synthesis of all three
isomers (2, 3 and 4- fluoromethcathinone) and by 1H, 13C and 19F NMR.
Date: August – September 2008 Place: Obtained as test purchases
from Internet suppliers. xxxxxxxx
Other substances present (if more than one case, specify for which one):
Psychoactive ingredients: None
Other ingredients: Products 2, 3, 4 and 5 contain caffeine
1 Biological (human) samples e.g. body fluids (urine, blood), tissues, hair, etc.
2 Actively collected by drug monitoring systems for monitoring or research purposes
Early-Warning System on New Psychoactive Substances Operating Guidelines
Annex III The EMCDDA-Europol Reporting Form
2
4. Physical description (in case of seizure/collection)
Product 1: Yellow Capsules Biorepublik
Form: powder tablet capsule liquid other (specify):
Colour: Yellow
For dosage unit: weight: diameter: shape: logo/markings:
433mg 19.1mm x 6.6mm
4. Physical description (in case of seizure/collection)
Product 2: White Capsules Biorepublik
Form: powder tablet capsule liquid other (specify):
Colour: White
For dosage unit: weight: diameter: shape: logo/markings:
391mg 18.8mm x 6.6mm
4. Physical description (in case of seizure/collection)
Product 3: Yellow/White Capsules Biorepublik
Form: powder tablet capsule liquid other (specify):
Colour: Yellow/white
For dosage unit: weight: diameter: shape: logo/markings:
303mg 18.9mm x 6.6mm
4. Physical description (in case of seizure/collection)
Product 4: Orange Capsules Biorepublik
Form: powder tablet capsule liquid other (specify):
Colour: Orange
Early-Warning System on New Psychoactive Substances Operating Guidelines
Annex III The EMCDDA-Europol Reporting Form
3
For dosage unit: weight: diameter: shape: logo/markings:
405mg 19.1mm x 6.4mm
4. Physical description (in case of seizure/collection)
Product 5: Charge +
Form: powder tablet capsule liquid other (specify):
Colour: Undecided
For dosage unit: weight: diameter: shape: logo/markings:
A small plastic pot containing a ziplock bag that contains about 200mg powder. It is
labelled as "novelty bath salts not for human consumption".
4. Physical description (in case of seizure/collection)
Product 6: S.C.D.
Form: powder tablet capsule liquid other (specify):
Colour: White
For dosage unit: weight: diameter: shape: logo/markings:
470mg 18.7mm x 6.7mm
4. Physical description (in case of seizure/collection)
Product 7: High Spirit
Form: powder tablet capsule liquid other (specify):
Colour: Yellow
For dosage unit: weight: diameter: shape: logo/markings:
430mg 18.8mm x 6.7mm
4. Physical description (in case of seizure/collection)
Product 8: Lift Neorganics
Form: powder tablet capsule liquid other (specify):
Early-Warning System on New Psychoactive Substances Operating Guidelines
Annex III The EMCDDA-Europol Reporting Form
4
Colour: Orange/white
For dosage unit: weight: diameter: shape: logo/markings:
370mg 18.8mm x 6.8mm
5. Circumstances: production trafficking distribution use
6. Price: retail (per dosage unit): wholesale:
€7-12 per item
7. Chemical precursors:
Not Known
8. Patterns of use:
Not Known
9. Other possible uses3:
Not Known
10. Effects in man
Not Known
Objectively observed:
Subjective (described by users):
11. Context of use
Not Known
User group(s):
Setting(s):
Availability at consumer level:
12. Indication on possible risks
Not Known
Health (individual):
Public health:
Social:
13. In case of production: large-scale small scale unknown
Has any form of organised crime been detected: yes no
14. In case of trafficking: large scale small scale unknown
national international
Has any form of organised crime been detected: yes no
15. In case of distribution: large-scale small scale unknown
Has any form of organised crime been detected: yes no
3 For example, for medical, industrial, ritual, cosmetic, etc., purposes
Was just looking for info on 3-FMC for safety/harm reduction purposes - in a way a little bit irresponsible for these companies to be selling this stuff to anyone without proper info on the substances,